Intelligent Bio Solutions INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 141,397 shares, representing 5.91% of Intelligent Bio Solutions Inc.'s common stock.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported a 9.99% stake in Intelligent Bio Solutions Inc., holding 163,571 shares.
NASDAQ
Alyeska Investment Group, L.P. and its affiliates have reported a 9.99% beneficial ownership stake in Intelligent Bio Solutions Inc. as of September 30, 2025.
NASDAQ
SCHEDULE 13G/A: Bigger Capital and Affiliates Update Passive Stake in Intelligent Bio Solutions, Capped by Warrant Limitations
Bigger Capital Fund L.P., District 2 Capital Fund L.P., and related entities, including Michael Bigger, have filed an amended Schedule 13G, disclosing their passive beneficial ownership in Intelligent Bio Solutions Inc., with holdings capped by a 4.99% beneficial ownership limitation on exercisable warrants.